Andrew S. Boyer
Executive Vice President · Amneal Pharmaceuticals, Inc.
- 2025
- Sep 2, 2026
- 6
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Andrew S. Boyer files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Nikita Shah - $4.14M in AMRX purchases and sales in the last 12 months
- Jason B. Daly - $3.77M in AMRX purchases and sales in the last 12 months
- John Kiely - $882K in AMRX purchases and sales in the last 12 months
- Ted C. Nark - $586K in AMRX purchases and sales in the last 12 months
- Deborah M. Autor - $451K in AMRX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Andrew S. Boyer?
Andrew S. Boyer is a corporate insider, tracked as Executive Vice President of Amneal Pharmaceuticals, Inc. (AMRX). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Andrew S. Boyer submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Andrew S. Boyer been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($2.92M) across all tracked filings.
